|

Longitudinal Study of CRS/HIPEC for Peritoneal Carcinomatoses

RECRUITINGSponsored by University of Regensburg
Actively Recruiting
SponsorUniversity of Regensburg
Started2016-10
Est. completion2026-07
Eligibility
Age18 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04108936

Summary

Longitudinal Study of the Effect of Cytoreductive Surgery and HIPEC in Patients With Peritoneal Carcinomatoses

Eligibility

Age: 18 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* suspicious peritoneal carcinomatosis

Exclusion Criteria:

* \<18 years

Conditions2

CancerPeritoneal Carcinomatosis

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.